The Prefyx PPS™ System eRegistry

NCT ID: NCT00688181

Last Updated: 2021-03-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-12-31

Study Completion Date

2009-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Registry to gather information about the long term use of the Prefyx PPS System for the treatment of Stress Urinary Incontinence (SUI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Registry to gather information about the long term use of the Prefyx PPS System which utilizes a pre-pubic surgical approach (device is to be placed in front of the pubic bone) for the treatment of SUI. No additional procedures are required beyond the physician's standard of care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Urinary Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects treated with the Prefyx PPS System

All patients presenting to the institution for treatment of female Stress Urinary Incontinence (SUI), excluding those patients meeting any of the contraindications as noted in the Directions For Use.

The Prefyx PPS™ Pre-pubic Sling System

Intervention Type DEVICE

device designed to treat female stress urinary incontinence (SUI).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The Prefyx PPS™ Pre-pubic Sling System

device designed to treat female stress urinary incontinence (SUI).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients presenting for treatment of female Urinary Stress Incontinence (SUI)

Exclusion Criteria

* Pregnant patients, patients with the potential for future growth or patients that are considering future pregnancies.
* Any patients with soft tissue pathology into which the implant is to be placed.
* Patients with any pathology which would compromise implant placement.
* Patients with any pathology, such as blood supply limitations or infections that would compromise healing.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Walsh, M.D.

Role: STUDY_DIRECTOR

Boston Scientific Corporation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

South Florida Urology Center

Pembroke Pines, Florida, United States

Site Status

OB/GYN Specialists of the Palm Beaches

West Palm Beach, Florida, United States

Site Status

Urology Specialists of Atlanta, LLC /Northside Hospital

Atlanta, Georgia, United States

Site Status

Affiliates in Urology

Westland, Michigan, United States

Site Status

HillCrest Medical Center

Tulsa, Oklahoma, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U8043

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pivotal Study of Voro Urologic Scaffold
NCT06873581 RECRUITING PHASE3